Signal transduction of erythropoietin in endothelial cells.

[1]  F. Luft,et al.  Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoforms. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[2]  D. Waxman,et al.  Intermittent Plasma Growth Hormone Triggers Tyrosine Phosphorylation and Nuclear Translocation of a Liver-Expressed, Stat 5-related DNA Binding Protein. , 1995, The Journal of Biological Chemistry.

[3]  A. Miyajima,et al.  Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. , 1995, The EMBO journal.

[4]  K. Chen,et al.  Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Y. Yazaki,et al.  The Proto-oncogene Product c-Cbl Becomes Tyrosine Phosphorylated by Stimulation with GM-CSF or Epo and Constitutively Binds to the SH3 Domain of Grb2/Ash in Human Hematopoietic Cells (*) , 1995, The Journal of Biological Chemistry.

[6]  Bernd Groner,et al.  Mediation of Growth Hormone-dependent Transcriptional Activation by Mammary Gland Factor/Stat 5 (*) , 1995, The Journal of Biological Chemistry.

[7]  F. Luft,et al.  High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. , 1995, Kidney international.

[8]  D. Schaper,et al.  Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. , 1995, Hypertension.

[9]  R. Carlini,et al.  Recombinant human erythropoietin stimulates angiogenesis in vitro. , 1995, Kidney international.

[10]  B. Groner,et al.  Colony‐stimulating factors and interferon‐γ activate a protein related to MGF‐Stat 5 to cause formation of the differentiation‐induced factor in myeloid cells , 1995, FEBS letters.

[11]  F. Luft,et al.  Differentiation of Vascular Smooth Muscle Cells and the Regulation of Protein Kinase C-α , 1995 .

[12]  B. Miller,et al.  Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylation. , 1994, Cell calcium.

[13]  N. Aoki,et al.  Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. , 1994, The Journal of biological chemistry.

[14]  F. Luft,et al.  LDL increases (CA++)i in human endothelial cells and augments thrombin-induced cell signalling. , 1994, The Journal of laboratory and clinical medicine.

[15]  J. Johnston,et al.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2 , 1994, Nature.

[16]  H. Haller,et al.  The effect of cyclosporine on calcium, protein kinase C, and sodium-proton exchange in platelets. , 1994, Transplantation.

[17]  A. Anagnostou,et al.  Erythropoietin receptor mRNA expression in human endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Pérez-Miranda,et al.  Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients. , 1994, Kidney international.

[19]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[20]  W. Vainchenker,et al.  Erythropoietin induces the association of phosphatidylinositol 3'-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. , 1993, European journal of biochemistry.

[21]  O. Silvennoinen,et al.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.

[22]  O. Silvennoinen,et al.  Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.

[23]  Y. Yazaki,et al.  Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. , 1993, Blood.

[24]  T. Pawson,et al.  Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. , 1993, Blood.

[25]  A. Dusso,et al.  Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. , 1993, Kidney international.

[26]  J. Cleveland,et al.  Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors , 1993, Molecular and cellular biology.

[27]  W. Farrar,et al.  Characterization of a 97-kDa phosphotyrosylprotein regulated by multiple cytokines. , 1992, The Journal of biological chemistry.

[28]  A. Mui,et al.  Erythropoietin-induced tyrosine phosphorylations in a high erythropoietin receptor-expressing lymphoid cell line. , 1992, Blood.

[29]  D. Barber,et al.  The erythropoietin receptor and the molecular basis of signal transduction. , 1992, Seminars in hematology.

[30]  W. Farrar,et al.  Association of the erythropoietin receptor with protein tyrosine kinase activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Pagel,et al.  Cocaine Depresses Myocardial Contractility and Prolongs Isovolumetric Relaxation in Conscious Dogs with Partial Autonomic Nervous System Blockade , 1992, Journal of cardiovascular pharmacology.

[32]  N. Casadevall,et al.  Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. , 1992, The Journal of biological chemistry.

[33]  M. Kuhn,et al.  Endothelin Release and Shift in Prostaglandin Balance Are Involved in the Modulation of Vascular Tone by Recombinant Erythropoietin , 1992, Journal of cardiovascular pharmacology.

[34]  H. Lodish,et al.  Homodimerization and constitutive activation of the erythropoietin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Lodish,et al.  In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130 , 1992, Molecular and cellular biology.

[36]  A. Raine,et al.  Effects of erythropoietin on blood pressure. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  M. Koury,et al.  The mechanism of erythropoietin action. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  G. Mills,et al.  A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptor. , 1991, Journal of immunology.

[39]  T. Akizawa,et al.  Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. , 1991, ASAIO transactions.

[40]  W. Zidek,et al.  Erythropoietin increases cytosolic free calcium concentration and thrombin induced changes in cytosolic free calcium in platelets from spontaneously hypertensive rats. , 1991, Biochemical and biophysical research communications.

[41]  R. Perlmutter,et al.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.

[42]  D. Quelle,et al.  Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Balter.  Cell cycle research: down to the nitty gritty. , 1991, Science.

[44]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[45]  A. D’Andrea,et al.  Activation of the erythropoietin receptor in stable lymphoid and myeloid transfectants. , 1991, Seminars in hematology.

[46]  K. Rahn,et al.  Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. , 1991, Kidney international.

[47]  A. Anagnostou,et al.  Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Jelkmann,et al.  Erythropoietin and blood pressure. , 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[49]  J. Walls,et al.  Erythropoietin does not induce vasoconstriction directly in human subcutaneous resistance arterioles. , 1989, Nephron.

[50]  E. Rozengurt.  Early signals in the mitogenic response. , 1986, Science.

[51]  A. A. Abdel-Latif.  Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. , 1986, Pharmacological reviews.